2017 Regular Session
|At the request of:|
|Chief Sponsors:||Representative Nosse, Senator Taylor|
|Bill Title:||Relating to inhalants; prescribing an effective date; providing for revenue raising that requires approval by a three-fifths majority.|
Imposes tax on distribution of inhalant product based on percentage of wholesale price.
Defines inhalant product as including inhalant-form nicotine but excluding cigarettes, tobacco products and cannabinoids. Requires licensing of place of business of inhalant product distributor. Establishes licensing program within Department of Revenue. Provides that licensing provisions become operative January 1, 2018. Applies to inhalant-form nicotine sold after January 1, 2018. Takes effect on 91st day following adjournment sine die.
|Fiscal Impact:||May Have Fiscal Impact, But No Statement Yet Issued|
|Revenue Impact:||May Have Revenue Impact, But No Statement Yet Issued|
|Measure Analysis:||Staff Measure Summary / Impact Statements|
|Current Location:||In House Committee|
|Current Committee:||House Committee On Revenue|